Join an expert panel of Knowledge Quarter Partners to discuss and debate the societal impact of disruption across science, medicine, arts, culture and technology. This debate will explore the challenges and opportunities of disruption and the positive impact it can have on our everyday lives.
Inequality, oppression, corruption, war and the destruction of nature are products of the Political Economy shaped to benefit the Structural Elite, and rooted in the hierarchical structure of society.
In this presentation, Clive Menzies will present a penetrating analysis of this interpretation of the undoubted present woes in today’s society and will argue from an apolitical standpoint that salvation lies in the dissolution of hierarchy. The challenge is how?
DEBATE: Jonathan Parker v Paul Carroll.
This is a hot topic and Jonathan Parker will argue that today’s large banks are a force for good, without them our quality of life would be dramatically diminished. Excessive bonuses are a bone of public contention but these are not a fault of the individual banker but of the embedded culture inherent to the capitalist system, to which mankind owes a huge debt. The motion will be opposed by Paul Carroll.
In this talk, Graham Bell will look at the schema that Walter Lippmann developed in the 1920s for conducting national elections and his justification of it. To what extent do his prescriptions reflect current General Elections in the UK?
Poverty in Britain is at post-war highs and – even with economic growth – is set to increase yet further. Food bank queues are growing, levels of severe deprivation have been rising, and increasing numbers of children are left with their most basic needs unmet.
In this talk, journalist Stewart Lansley will take us through the critical factors that have lead us to this parlous state, with following discussions on possible resolutions.
Our society produces unprecedented amounts of data today. Some of these data will be used in the health domain. Also the creation of genetic data has become much faster, and much less expensive; the result is that people can get their genome (all their DNA) analysed by private companies, and sometimes even in the clinic.
Although experts disagree about whether or not this is a positive development, virtually everybody agrees that we are far away from understanding what our genome data mean. Contrary to the expectation of some people, knowing our genome does not tell us what we will die of, or how long we will live.